GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
Paris (ots/PRNewswire) - - GenOdyssee has Received Notice of Allowance of United States Patent Application Covering it's Lead HCV Interferon-Alpha Product GEA007.1, a Natural Protein With Improved Anti-HCV Genotype 1 Activity GenOdyssee S.A., a biotechnology company dedicated to the discovery and ...